.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
Dow
QuintilesIMS
Chinese Patent Office
Covington
Citi
Moodys
Fish and Richardson
Baxter

Generated: February 24, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 01203090

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Gilead Sciences IncCOMPLERAemtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarateTABLET;ORAL202123-001Aug 10, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF HIV INFECTION
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYIN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, IS INDICATED FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN ANTIRETROVIRAL TREATMENT-NAIVE ADULT PATIENTS, AS SET FORTH IN THE LABELING, INCLUDING I&U SECTION
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYIN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-NAIVE ADULT PATIENTS WITH HIV-1 RNA LESS THAN OR EQUAL TO 100,000 AT THE START OF THERAPY
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYIN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-NAIVE PATIENTS WITH HIV-1 RNA LESS THAN OR EQUAL TO 100,000 AT THE START OF THEARPY
Viiv HlthcareJULUCAdolutegravir sodium; rilpivirine hydrochlorideTABLET;ORAL210192-001Nov 21, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF HIV INFECTION
Gilead Sciences IncODEFSEYemtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarateTABLET;ORAL208351-001Mar 1, 2016RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF HIV INFECTION
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Gilead Sciences IncCOMPLERAemtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarateTABLET;ORAL202123-001Aug 10, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
Janssen ProdsEDURANTrilpivirine hydrochlorideTABLET;ORAL202022-001May 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
Viiv HlthcareJULUCAdolutegravir sodium; rilpivirine hydrochlorideTABLET;ORAL210192-001Nov 21, 2017RXYesYes➤ Try a Free Trial➤ Try a Free TrialYY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist